📊 IDXX Key Takeaways
Is IDXX a Good Investment? Thesis Analysis
IDEXX demonstrates exceptional operational excellence with 31.6% operating margins, 66% ROE, and accelerating earnings growth (EPS +22.6% vs revenue +10.4%), indicating strong operating leverage in its diagnostics business. The company maintains a conservative 0.28x debt/equity ratio while generating robust $1.1B free cash flow, providing substantial financial flexibility for growth and shareholder returns.
Why Buy IDXX? Key Strengths
- Exceptional profitability: 61.8% gross margin and 31.6% operating margin demonstrate strong pricing power and operational efficiency
- Outstanding capital returns: 66% ROE and 31.6% ROA significantly exceed peer averages, indicating exceptional asset deployment
- Accelerating earnings growth: EPS growing 22.6% YoY vs revenue growth of 10.4% signals strong operational leverage and margin expansion
- Conservative financial structure: 0.28x debt/equity ratio with 171.9x interest coverage provides substantial financial flexibility
- Strong cash generation: $1.1B free cash flow with 24.6% FCF margin demonstrates resilient business model and effective capital conversion
IDXX Investment Risks to Consider
- Liquidity compression: Current ratio of 1.23x and quick ratio of 0.90x suggest near-term working capital constraints; requires monitoring
- Elevated insider activity: 18 Form 4 filings in 90 days warrants investigation into transaction nature and motivations
- Execution risk: Sustaining 31.6% operating margins amid inflationary pressures and competitive dynamics in diagnostics market
Key Metrics to Watch
- Gross margin trend - sustainability amid cost inflation and competitive pressures
- Organic revenue growth rate - distinguishing organic expansion from acquisition contributions
- Free cash flow conversion - maintenance of 24.6% FCF margin relative to net income
- Current and quick ratio trends - liquidity position monitoring
- Debt levels and leverage ratios - capital structure evolution
IDXX Financial Metrics
💡 AI Analyst Insight
The 24.6% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments.
IDXX Profitability Ratios
IDXX vs Default Sector
How IDEXX LABORATORIES INC /DE compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is IDXX Overvalued or Undervalued?
Based on fundamental analysis, IDEXX LABORATORIES INC /DE appears fundamentally strong relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
IDXX Balance Sheet & Liquidity
IDXX 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: IDEXX LABORATORIES INC /DE's revenue has grown significantly by 34% over the 5-year period, indicating strong business expansion. The most recent EPS of $10.06 reflects profitable operations.
IDXX Growth Metrics (YoY)
IDXX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $975.5M | $203.3M | $2.80 |
| Q2 2025 | $1.0B | $203.3M | $2.44 |
| Q1 2025 | $964.1M | $235.6M | $2.81 |
| Q3 2024 | $915.5M | $203.3M | $2.53 |
| Q2 2024 | $943.6M | $203.3M | $2.44 |
| Q1 2024 | $900.2M | $214.1M | $2.55 |
| Q3 2023 | $841.7M | $132.0M | $2.15 |
| Q2 2023 | $860.5M | $132.0M | $1.56 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
IDXX Capital Allocation
IDXX SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for IDEXX LABORATORIES INC /DE (CIK: 0000874716)
📋 Recent SEC Filings
❓ Frequently Asked Questions about IDXX
What is the AI rating for IDXX?
IDEXX LABORATORIES INC /DE (IDXX) has an AI rating of STRONG BUY with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are IDXX's key strengths?
Claude: Exceptional profitability: 61.8% gross margin and 31.6% operating margin demonstrate strong pricing power and operational efficiency. Outstanding capital returns: 66% ROE and 31.6% ROA significantly exceed peer averages, indicating exceptional asset deployment.
What are the risks of investing in IDXX?
Claude: Liquidity compression: Current ratio of 1.23x and quick ratio of 0.90x suggest near-term working capital constraints; requires monitoring. Elevated insider activity: 18 Form 4 filings in 90 days warrants investigation into transaction nature and motivations.
What is IDXX's revenue and growth?
IDEXX LABORATORIES INC /DE reported revenue of $4.3B.
Does IDXX pay dividends?
IDEXX LABORATORIES INC /DE does not currently pay dividends.
Where can I find IDXX SEC filings?
Official SEC filings for IDEXX LABORATORIES INC /DE (CIK: 0000874716) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is IDXX's EPS?
IDEXX LABORATORIES INC /DE has a diluted EPS of $13.08.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is IDXX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, IDEXX LABORATORIES INC /DE has a STRONG BUY rating with 88% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is IDXX stock overvalued or undervalued?
Valuation metrics for IDXX: ROE of 66.0% (sector avg: 15%), net margin of 24.6% (sector avg: 12%). Higher ROE suggests strong returns relative to peers.
Should I buy IDXX stock in 2026?
Our dual AI analysis gives IDEXX LABORATORIES INC /DE a combined STRONG BUY rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is IDXX's free cash flow?
IDEXX LABORATORIES INC /DE's operating cash flow is $1.2B, with capital expenditures of $124.7M. FCF margin is 24.6%.
How does IDXX compare to other Default stocks?
Vs Default sector averages: Net margin 24.6% (avg: 12%), ROE 66.0% (avg: 15%), current ratio 1.23 (avg: 1.8).